← Back to Search
Magnetic Targeting For Site-specific Drug Delivery: Applications And Clinical Potential
B. Polyak, G. Friedman
Published 2009 · Materials Science
Download PDFAnalyze on Scholarcy
Background: Magnetic vehicles are very attractive for delivery of therapeutic agents as they can be targeted to specific locations in the body through the application of a magnetic field gradient. The magnetic localization of a therapeutic agent results in the concentration of the therapy at the target site consequently reducing or eliminating the systemic drug side effects. Objective: The aim of this review is to provide an update on the progress made in the development of the magnetic targeting technique addressing characteristics of the magnetic carriers and limitations of the current targeting magnet systems. Methods: This review discusses fundamental requirements for the optimal formulation of the magnetic carrier, current applications and potentially new approaches for the magnetically mediated, site-specific localization of therapeutic agents, including drugs, genes and cells. Results/conclusion: More efficient targeting magnetic systems in combination with prolonged circulation lifespan and carriers' surface recognition properties will improve the targeting efficiency of magnetic nanocarriers and enhance therapeutic agent availability at the molecular site of agent action. The main future magnetic targeting applications were categorized emphasizing the most promising directions and possible strategies for improving the magnetic targeting technique.
This paper references
Magnetizable needles and wires--modeling an efficient way to target magnetic microspheres in vivo.
Gh Iacob (2004)
Enhancing and targeting nucleic acid delivery by magnetic force
C. Plank (2003)
Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis.
J. Rejman (2004)
Preparation and properties of magnetic nano- and microsized particles for biological and environmental separations.
D. Horák (2007)
Tumor remission in Yoshida sarcoma-bearing rts by selective targeting of magnetic albumin microspheres containing doxorubicin.
K. Widder (1981)
Very interesting article demonstrating that magnetic forces can be used to rapidly place endothelial cells at the site of a permanently magnetized intravascular stent
Selective Inductive Heating of Lymph Nodes
R. Gilchrist (1957)
Magnetically targeted endothelial cell localization in stented vessels.
S. Pislaru (2006)
Metabolic instability of plasmid DNA in the cytosol: a potential barrier to gene transfer
D. Lechardeur (1999)
Analysis of plasma protein adsorption on polymeric nanoparticles with different surface characteristics.
M. Lück (1998)
Magnetic PECA nanoparticles as drug carriers for targeted delivery: Synthesis and release characteristics
J. Yang (2006)
Magnetic Nanoparticles as Contrast Agents for Medical Diagnosis
L. Tiefenauer (2007)
Microscopic artificial swimmers
R. Dreyfus (2005)
High field gradient targeting of magnetic nanoparticle-loaded endothelial cells to the surfaces of steel stents
B. Polyak (2008)
Stereotactic thrombosis of intracranial aneurysms.
J. Alksne (1970)
Magnetic drug targeting: biodistribution and dependency on magnetic field strength ☆
Ch. Alexiou (2002)
Magnetofection Potentiates Gene Delivery to Cultured Endothelial Cells
F. Kroetz (2003)
Magnetic separation techniques in diagnostic microbiology.
O. Olsvik (1994)
Preparation and application of magnetic polymers for targeting of drugs
K. Mosbach (1979)
Synthesis and characterization of highly-magnetic biodegradable poly(d,l-lactide-co-glycolide) nanospheres.
X. Liu (2007)
Magnetically Guided Rat Erythrocytes Bearing Isoniazid: Preparation, Characterization, and Evaluation
S. Jain (1997)
Japan) assignee. Manufacture of needle-like magnetic iron oxide particle powders. Application: JP, JP patent 93-193099
K Fujita (1995)
An overview of responsive MRI contrast agents for molecular imaging.
Byunghee Yoo (2008)
Novel dextran–spermine conjugates as transfecting agents: comparing water-soluble and micellar polymers
H. Eliyahu (2005)
Long-circulating iron oxides for MR imaging
R. Weissleder (1995)
A High Field Gradient Magnet for Magnetic Drug Targeting
C. Alexiou (2006)
Interactions between isolated hepatocytes and kupffer cells in iron metabolism: A possible role for ferritin as an iron carrier protein
J. Sibille (1988)
Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors.
A. Lübbe (1996)
In vitro and in vivo toxicity of magnetic microspheres
U. Häfeli (1999)
Poly(D,L-lactide-co-glycolide) microcomposite containing magnetic iron core nanoparticles as a drug carrier
Sweta H. Naik (2008)
A two-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy.
S. Moghimi (2005)
Principles of magnetodynamic chemotherapy.
M. Babincová (2004)
Capture of stealth nanoparticles by the body's defences.
S. Moghimi (2001)
Biocompatible stabilizers in the preparation of PLGA nanoparticles: a factorial design study.
J. Vandervoort (2002)
Biomedical applications of superparamagnetic iron oxide nanoparticles encapsulated within chitosan
E. Kim (2007)
Detoxification of blood using injectable magnetic nanospheres: A conceptual technology description
M. Kaminski (2005)
Colloidal stability of magnetite/poly(lactic acid) core/shell nanoparticles.
S. A. Gómez-Lopera (2006)
Delivery of superparamagnetic nanoparticles for local chemotherapy after intraarterial infusion and magnetic drug targeting.
C. Alexiou (2007)
Non-stealth (poly(lactic acid/albumin)) and stealth (poly(lactic acid-polyethylene glycol)) nanoparticles as injectable drug carriers
T. Verrecchia (1995)
Adsorption/desorption of human serum albumin at the surface of poly(lactic acid) nanoparticles prepared by a solvent evaporation process.
T. Verrecchia (1993)
Magnetic Steering of Iron Oxide Microparticles Using Propulsion Gradient Coils in MRI
J.-B. Mathieu (2006)
Ultrasound-mediated transdermal protein delivery
S. Mitragotri (1995)
Drug loaded magnetic nanoparticles for cancer therapy
R. Jurgons (2006)
Magnetic guidance of drug-carrying Polyak & Friedman Expert Opin. Drug Deliv
A Senyei (1978)
inventor (University Technology Corp., USA) assignee
DCF Chan (1998)
inventors; (Toda Kogyo Corp, Japan) assignee. Manufacture of needle-like magnetic iron oxide particle powders
K Fujita (1993)
Microsphere-Mediated Delivery of Recombinant AAV Vectors In Vitro And In Vivo [abstract
C Mah (2000)
Magnetic Nanoparticles for Cancer Therapy
G. F. Goya (2008)
Structure of dextran–magnetite complex: relation between conformation of dextran chains covering core and its molecular weight
T. Kawaguchi (2000)
Preparation of poly ɛ-caprolactone nanoparticles containing magnetite for magnetic drug carrier
J. M. Yang (2006)
Long-circulating and target-specific nanoparticles: theory to practice.
S. Moghimi (2001)
Evaluation of nanoparticles as drug-delivery systems. III: materials, stability, toxicity, possibilities of targeting, and use.
J. Kreuter (1983)
Stress wave attenuation in ceramic plates
N. Naik (2008)
Detection and determination of surface levels of poloxamer and PVA surfactant on biodegradable nanospheres using SSIMS and XPS.
P. Scholes (1999)
Biodegradable PEGylated microspheres and nanospheres
V. Sinha (2004)
An approach to targeted drug delivery based on uniform magnetic fields
Z. G. Forbes (2003)
Magnetically controlled metallic thrombosis of intracranial aneurysms. A preliminary report.
J. Alksne (1965)
Biodegradation and biocompatibility of PLA and PLGA microspheres.
Magnetofection: enhancement and localization of gene delivery with magnetic particles under the infl uence of a magnetic fi eld
C Plank (2000)
The Magnetofection Method: Using Magnetic Force to Enhance Gene Delivery
C. Plank (2003)
Folate receptor-targeted immunotherapy of cancer: mechanism and therapeutic potential.
Y. Lu (2004)
Applications of nanotechnology in drug delivery systems for the treatment of cancer and diabetes
K. Subramani (2006)
Evaluation of systemic chemotherapy with magnetic liposomal doxorubicin and a dipole external electromagnet
H. Nobuto (2004)
Remotely Triggered Release from Magnetic Nanoparticles
Austin M. Derfus (2007)
Targeted drug delivery to magnetic implants for therapeutic applications
B. Yellen (2005)
Improved method of recombinant AAV2 delivery for systemic targeted gene therapy.
C. Mah (2002)
Encapsulation of indomethacin in magnetic biodegradable polymer nanoparticles
V. Závišová (2007)
Novel methodology for fabrication of tissue-engineered tubular constructs using magnetite nanoparticles and magnetic force.
A. Ito (2005)
Drug release and release mechanism of prednisolone loaded Solid Lipid Nanoparticles
A. Z. Mühlen (1998)
Suspension of Fe(3)O(4) nanoparticles stabilized by chitosan and o-carboxymethylchitosan.
Aiping Zhu (2008)
Validation of High Gradient Magnetic Field Based Drug Delivery to Magnetizable Implants Under Flow
Z. G. Forbes (2008)
Hydrodynamics of magnetic drug targeting.
P. A. Voltairas (2002)
Selective targeting of magnetic albumin microspheres containing low-dose doxorubicin: total remission in Yoshida sarcoma-bearing rats.
K. Widder (1983)
An update on iron metabolism: Summary of the Fifth International Conference on Disorders of Iron Metabolism
H. Bonkovsky (1996)
Use of endothelial cells containing superparamagnetic microspheres to improve endothelial cell delivery to arterial surfaces after angioplasty.
P. M. Consigny (1999)
Magnetite-loaded carrier erythrocytes as contrast agents for magnetic resonance imaging.
M. Brähler (2006)
Synthesis of Ibuprofen Loaded Magnetic Solid Lipid Nanoparticles
X.J. Pang (2007)
A stimulus-responsive magnetic nanoparticle drug carrier: magnetite encapsulated by chitosan-grafted-copolymer.
Q. Yuan (2008)
Preparation of microspheres by the solvent evaporation technique.
Nanoparticulate delivery of suicide DNA to murine prostate and prostate tumors
W. Peng (2007)
Biodegradable long-circulating polymeric nanospheres.
R. Gref (1994)
Influence of the stabilizer coating layer on the purification and freeze-drying of poly(D,L-lactic acid) nanoparticles prepared by an emulsion-diffusion technique.
D. Quintanar-Guerrero (1998)
Magnetically controlled intravascular catheter.
J. Alksne (1968)
Magnetically controlled intravascular catheter.
Alksne Jf (1968)
Magnetic drug targeting--biodistribution of the magnetic carrier and the chemotherapeutic agent mitoxantrone after locoregional cancer treatment.
C. Alexiou (2003)
Design and Evaluation of Magnetic Fields for Nanoparticle Drug Targeting in Cancer
B. Gleich (2007)
Intracellular dynamics of the gene delivery vehicle polyethylenimine during transfection: investigation by two-photon fluorescence correlation spectroscopy.
Jean-Pierre Clamme (2003)
Ferromagnetic silicone necrosis of hypernephromas by selective vascular occlusion to the tumor: a new technique.
R. Turner (1975)
Effect of solvent on the characteristics of pentamidine loaded microcapsule.
T. Mandal (1999)
Targeted magnetic resonance imaging contrast agents.
S. Caruthers (2006)
Locoregional cancer treatment with magnetic drug targeting.
C. Alexiou (2000)
'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption.
The in vivo and in vitro degradation of poly(glycolic acid) suture material as a function of applied strain.
N. D. Miller (1984)
Permanently Linked Monodisperse Paramagnetic Chains
E. Furst (1998)
Hepatocellular carcinoma: regional therapy with a magnetic targeted carrier bound to doxorubicin in a dual MR imaging/ conventional angiography suite--initial experience with four patients.
M. Wilson (2004)
Clinical applications of magnetic drug targeting.
A. Lübbe (2001)
Magnetic microparticle steering within the constraints of an MRI system: proof of concept of a novel targeting approach
J. Mathieu (2007)
Degradation rates of oral resorbable implants (polylactates and polyglycolates): rate modification with changes in PLA/PGA copolymer ratios.
R. Miller (1977)
A polymer library approach to suicide gene therapy for cancer.
D. Anderson (2004)
Stealth PLA-PEG Nanoparticles as Protein Carriers for Nasal Administration
M. Tobío (2004)
Microscopic artifi cial swimmers
R Dreyfus (2005)
•• Fundamental study on the long circulating theory of the colloidal systems
Magnetic albumin microspheres in drug delivery
K J Widder (1984)
Surface-modified biodegradable albumin nano- and microspheres. II: effect of surface charges on in vitro phagocytosis and biodistribution in rats.
M. Roser (1998)
Preparation of poly epsilon-caprolactone nanoparticles containing magnetite for magnetic drug carrier.
J. Yang (2006)
Preparation and properties of superparamagnetic nanoparticles with narrow size distribution and biocompatible
W. Jiang (2004)
PEI-based vesicle-polymer hybrid gene delivery system with improved biocompatibility.
A. Brownlie (2004)
A novel magnetic approach to enhance the efficacy of cell-based gene therapies
M. Muthana (2008)
Solid lipospheres of doxorubicin and idarubicin
R. Cavalli (1993)
comparing water-soluble Magnetic targeting for site-specifi c drug delivery: applications and clinical potential 70 Expert Opin
H Eliyahu (2009)
• In vitro and in vivo demonstration of the ability to deliver genes using non-viral vectors associated with magnetic carriers
F Scherer (2002)
Targeted delivery of magnetic aerosol droplets to the lung
P. Dames (2007)
Tissue engineering using magnetite nanoparticles and magnetic force: heterotypic layers of cocultured hepatocytes and endothelial cells.
A. Ito (2004)
Magnetite/poly(alkylcyanoacrylate) (core/shell) nanoparticles as 5-Fluorouracil delivery systems for active targeting.
J. L. Arias (2008)
Drug-carrier property of albumin microspheres in chemotherapy. IV. Antitumor effect of single-shot or multiple-shot administration of microsphere-entrapped 5-fluorouracil on Ehrlich ascites or solid tumor in mice.
Y. Morimoto (1980)
Magnetic Microspheres: A Model System for Site Specific Drug Delivery in Vivo 1
K. Widder (1978)
Stealth Me.PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system.
D. Bazile (1995)
Transdermal Drug Delivery Using Low-Frequency Sonophoresis
S. Mitragotri (2004)
Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake.
Y. Zhang (2002)
Magnetic mitoxantrone nanoparticle detection by histology, X-ray and MRI after magnetic tumor targeting
C. Alexiou (2001)
A multicenter, phase I/II trial of hepatic intra-arterial delivery of doxorubicin hydrochloride adsorbed to magnetic targeted carriers in patients with hepatocellular carcinoma
J Koda (2002)
Microsphere-Mediated Delivery of Recombinant AAV Vectors In Vitro And In Vivo
Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers.
S. Feng (2001)
Remote control of cellular behaviour with magnetic nanoparticles.
J. Dobson (2008)
Resorption rate, route, route of elimination, and ultrastructure of the implant site of polylactic acid in the abdominal wall of the rat.
J. M. Brady (1973)
Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo
Friedrich Scherer (2002)
Magnetic nanoparticles for drug delivery
J. Dobson (2006)
Magnetism in medicine.
C. Breathnach (1983)
Quantitative measurements of L-dopa therapy in Parkinson's disease.
Webster Dd (1969)
10989 -93 Magnetic targeting for site-specifi c drug delivery: applications and clinical potential 68 Expert Opin
Armes SP Takabayashi Y et al. Synthesis of Biocompatible Yuan JJ (2009)
applications and clinical potential 66 Expert Opin
D Quintanar-Guerrero (2009)
Contrast agents for MRI
E. A. Waters (2008)
Application of surface acoustic waves for optimisation of biocompatibility of carboxymethylated dextran surfaces
G. Markovic (2006)
Factors influencing the body distribution of polyacrylic nanoparticles
J. Kreuter (1985)
Magnetic microcapsules for targeted delivery of anticancer drugs.
T. Kato (1984)
Biocompatible magnetic polymer carriers for in vivo radionuclide delivery.
W. Schuett (1999)
Thymopentin in solid lipid nanoparticles
S. Morel (1996)
Drug-carrier property of albumin microspheres in chemotherapy. II. Preparation and tissue distribution in mice of microsphere-entrapped 5-fluorouracil.
K. Sugibayashi (1979)
Preliminary investigation of the feasibility of magnetic propulsion for future microdevices in blood vessels.
J. Mathieu (2005)
Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymers.
D. Quintanar-Guerrero (1998)
Effective targeting of magnetic radioactive 90Y-microspheres to tumor cells by an externally applied magnetic field. Preliminary in vitro and in vivo results.
U. Häfeli (1995)
Application: US, US patent 96-617685, 5753477
Magneto-Biolistic Methods (1998)
Degradation phenomena of two linear aliphatic polyester fibres used in medicine and surgery
Chih-Chang Chu (1985)
Biodegradation of surgical polymers
D. Williams (1982)
Magnetic and fluorescent multifunctional chitosan nanoparticles as a smart drug delivery system
L. Li (2007)
Exploring polyethylenimine‐mediated DNA transfection and the proton sponge hypothesis
A. Akinc (2005)
Preparation and characterization of biodegradable magnetic carriers by single emulsion-solvent evaporation
Xianqiao Liu (2007)
Real-Time MRI-Based Control of a Ferromagnetic Core for Endovascular Navigation
S. Tamaz (2008)
Magnetic and fl uorescent multifunctional chitosan nanoparticles as a smart drug delivery system
L Li (2007)
Dextran-spermine-based polyplexes--evaluation of transgene expression and of local and systemic toxicity in mice.
H. Eliyahu (2006)
Targeting Tumors with Magnetic Drugs
A. Lübbe (2002)
Streptavidin paramagnetic particles provide a choice of three affinity-based capture and magnetic concentration strategies for retroviral vectors.
C. Hughes (2001)
Development of superparamagnetic nanoparticles for MRI: effect of particle size, charge and surface nature on biodistribution.
C. Chouly (1996)
Mechanisms of polymer degradation in implantable devices. 2. Poly(DL-lactic acid).
S. A. Ali (1993)
A method for the preparation of submicron particles of sparingly water-soluble drugs by precipitation in oil-in-water emulsions. I: Influence of emulsification and surfactant concentration.
B. Sjoestroem (1993)
Biomedical applications of magnetic fluids. i. Magnetic guidance of ferro-colloid-entrapped albumin microsphere for site specific drug delivery in vivo.
Y. Morimoto (1980)
Clinical hyperthermia of prostate cancer using magnetic nanoparticles: Presentation of a new interstitial technique
M. Johannsen (2005)
New ferro-carbon adsorbents for magnetically guided transport of anti-cancer drugs
A. Kuznetsov (1999)
Camoufl age nanospheres: A new approach to bypassing phagocytic blood clearance by surface modifi ed particulate carriers
BG Mueller (1993)
Evaluation of nanoparticles as drug-delivery systems I: preparation methods
J. Kreuter (1983)
cancer xenograft mouse model
Preparation and Characterization of Dextran Magnetite-Incorporated Thermosensitive Liposomes: An on-line Flow System for Quantifying Magnetic Responsiveness
E. Viroonchatapan (2004)
Quaternary ammonium polysaccharides for gene delivery.
I. Yudovin-Farber (2005)
Magnetic poly ε-caprolactone nanoparticles containing Fe3O4 and gemcitabine enhance anti-tumor effect in pancreatic cancer xenograft mouse model
Jingu Gang (2007)
Nuclear gene delivery: the Trojan horse approach
A. Rolland (2006)
Magnetic fluid hyperthermia (MFH)reduces prostate cancer growth in the orthotopic Dunning R3327 rat model
M. Johannsen (2005)
Biocompatible superparamagnetic iron oxide nanoparticle dispersions stabilized with poly(ethylene glycol)-oligo(aspartic acid) hybrids.
S. Wan (2007)
Optimization of iron oxide nanoparticles encapsulation within poly(d,l-lactide-co-glycolide) sub-micron particles.
L. N. Okassa (2007)
Development and characterization of solid lipid nanoparticles loaded with magnetite.
M. Igartua (2002)
The POD and its applications.
E. Frei (1966)
Organspezifische Applikation von pharmazeutisch aktiven Substanzen über zellulare Trägersysteme / Organ Specific Application of Drugs by Means of Cellular Capsule Systems
U. Zimmermann (1976)
Preclinical experiences with magnetic drug targeting: tolerance and efficacy.
A. Lübbe (1996)
Magnetic poly e-caprolactone nanoparticles containing Fe3O4 and gemcitabine enhance anti-tumor effect in pancreatic
J Gang (2009)
Functionalized magnetic nanoparticles for tissue engineering
A Ito (2007)
Colloidal Stability of Magnetite/Poly
S A Gomez-Lopera
Heat generation of aqueously dispersed CoFe2O4 nanoparticles as heating agents for magnetically activated drug delivery and hyperthermia
Deok-ryeong Kim (2008)
Preparation of Well-Dispersed Superparamagnetic Iron Oxide Nanoparticles in Aqueous Solution with Biocompatible N-Succinyl-O-carboxymethylchitosan
Aiping Zhu (2008)
MRI after magnetic drug targeting in patients with advanced solid malignant tumors
A. Lemke (2004)
Synthesis of Poly(DL-Lactide-Co-Glycolide) Nanoparticles with Entrapped Magnetite by Emulsion Evaporation Method
C. Astete (2005)
Single-dose toxicity study of hepatic intra-arterial infusion of doxorubicin coupled to a novel magnetically targeted drug carrier.
S. Goodwin (2001)
Ultrastructural disposition of adriamycin-associated magnetic albumin microspheres in rats.
P. Gupta (1989)
Magnetically directed poly(lactic acid) 90Y-microspheres: novel agents for targeted intracavitary radiotherapy.
U. Häfeli (1994)
Synthesis of biocompatible poly[2-(methacryloyloxy)ethyl phosphorylcholine]-coated magnetite nanoparticles.
J-J Yuan (2006)
Bone tissue engineering with human mesenchymal stem cell sheets constructed using magnetite nanoparticles and magnetic force.
K. Shimizu (2007)
Magnetic albumin microspheres in drug delivery. Microspheres Drug Ther: Pharm, Immunol
KJ Widder (1984)
Organ specifi c application of drugs using cellular capsule systems
U Zimmermann (1976)
Very good review of principles of magnetic drug and nucleic acid delivery discussing the facts and potentials of the technique for research and therapeutic applications
Magnetic guidance of drug‐carrying microspheres
A. Senyei (1978)
EXPERIMENTAL APPROACH IN THE USE AND MAGNETIC CONTROL OF METALLIC IRON PARTICLES IN THE LYMPHATIC AND VASCULAR SYSTEM OF DOGS AS A CONTRAST AND ISOTOPIC AGENT.
P. Meyers (1963)
Nanomedicine: current status and future prospects
S. Moghimi (2005)
Preparation of biodegradable microcapsules containing zidovudine (AZT) using solvent evaporation technique.
T. Mandal (1996)
ERYTHROCYTES BASED DELIVERY OF ISONIAZID : PREPARATION AND IN-VITRO CHARACTERIZATION
S. Jain (1995)
Preparation and characterization of superparamagnetic iron oxide nanoparticles stabilized by alginate.
H. Ma (2007)
Review Biodegradation of surgical polymers
D. F. Williams (1982)
Comparative study of the association of itraconazole with colloidal drug carriers
Stéphanie de Chasteigner (1996)
Positive contrast magnetic resonance imaging of cells labeled with magnetic nanoparticles
C. Cunningham (2005)
Superparamagnetic iron oxide: pharmacokinetics and toxicity.
R. Weissleder (1989)
Biodistribution, clearance, and biocompatibility of iron oxide magnetic nanoparticles in rats.
Tapan Jain (2008)
Preparation and in vitro characterization of a magnetically responsive ibuprofen-loaded erythrocytes carrier.
S. Vyas (1994)
Biomedical applications of magnetic fl uids
Y Morimoto (1980)
USA) assignee. Magnetophoretic particles and apparatus for delivery of substances into cells. Application: US, US patent 94-319521
Magnetically driven plasmid DNA delivery with biodegradable polymeric nanoparticles
M. Chorny (2007)
Magnetic Driven Alginate Nanoparticles for Targeted Drug Delivery
G. Ciofani (2008)
Dextran–spermine polycation: an efficient nonviral vector for in vitro and in vivo gene transfection
H. Hosseinkhani (2004)
Proteolytic surface functionalization enhances in vitro magnetic nanoparticle mobility through extracellular matrix.
S. Kuhn (2006)
Magnetically modulated therapeutic systems.
U. Häfeli (2004)
Magnetofection: Enhancing and Targeting Gene Delivery with Superparamagnetic Nanoparticles and Magnetic Fields
C. Plank (2003)
Controlled pulsatile drug release from a ferrogel by a high-frequency magnetic field
S. Hu (2007)
Nuclear entry of nonviral vectors
D. Dean (2005)
inventors; (USA) assignee. Magnetophoretic particles and apparatus for delivery of substances into cells
AR Kuehnle (1996)
inventors; (Toda Kogyo Corp, Japan) assignee. Needle-like ferric oxide or iron hydroxyoxide granulated material, its manufacture, and manufacture of magnetic iron oxide powder for magnetic recording
K Yamashita (1993)
The degradation and biocompatibility of suture materials
CC Chu (1985)
New ferrocarbon adsorbents for magnetically guided transport of anticancer drugs
AA Kuznetsov (1999)
Influence of the stabilizer coating layer on the purification and freeze-drying of poly(D,L-lactic acid) nanoparticles prepared by an emulsion-diffusion technique
Quai Ernest-Ansermet (1998)
Cytotoxicity of magnetite-loaded polylactide, polylactide/glycolide particles and solid lipid nanoparticles
R. Mueller (1996)
Magnetic nanoparticles with dual functional properties: drug delivery and magnetic resonance imaging.
Tapan Jain (2008)
Iron oxide nanoparticles for sustained delivery of anticancer agents.
Tapan Jain (2005)
Effect of formulation and processing factors on the characteristics of biodegradable microcapsules of zidovudine.
T. Mandal (1996)
Using magnetic forces to enhance non-viral gene transfer to airway epithelium in vivo
S. Xenariou (2006)
Magnetic Forces Enable Rapid Endothelialization of Synthetic Vascular Grafts
S. Pislaru (2006)
Process and formulation variables in the preparation of injectable and biodegradable magnetic microspheres
H. Zhao (2007)
Development and characterization of sub-micron poly(D,L-lactide-co-glycolide) particles loaded with magnetite/maghemite nanoparticles.
L. Ngaboni Okassa (2005)
Role of endogenous endonucleases and tissue site in transfection and CpG-mediated immune activation after naked DNA injection.
M. E. Barry (1999)
This paper is referenced by
Evaluation of biological effects and possible mechanisms of action of static magnetic field
Chekhun Vf (2012)
Design and fabrication of non-superparamagnetic high moment magnetic nanoparticles for bioapplications
Punnapob Punnakitikashem (2010)
Properties of biogenic magnetite nanoparticles in the radula of chiton Acanthochiton rubrolineatus lischke
Chuanlin Liu (2011)
Magnetic Nano-Systems in Drug Delivery and Biomedical Applications
Saritha Shetty (2018)
Use of Oppositely-Polarized External Magnets to Improve the Accumulation and Penetration of Magnetic Nanocarriers into Solid Tumors.
J. F. Liu (2019)
Externally Controlled Cellular Transport of Magnetic Iron Oxide Particles with Polysaccharide Surface Coatings
K. Cho (2019)
Magnetic Fluid Hyperthermia Based on Magnetic Nanoparticles: Physical Characteristics, Historical Perspective, Clinical Trials, Technological Challenges, and Recent Advances
H. Etemadi (2020)
Magnetic‐Nanoparticle‐Based Immunoassays‐on‐Chip: Materials Synthesis, Surface Functionalization, and Cancer Cell Screening
Y. Zhu (2016)
Microfluidic Devices for Nanodrug Delivery
C. Kleinstreuer (2010)
Magnetic control of cellular processes using biofunctional nanoparticles
Cornelia Monzel (2017)
Eco-friendly polymer-based nanocomposites for pharmaceutical applications
I. I. Muhamad (2015)
Magnetically actuated tissue engineered scaffold: insights into mechanism of physical stimulation.
Yulia Sapir-Lekhovitser (2016)
A review of magnet systems for targeted drug delivery.
Ya-li Liu (2019)
Interaction of a flavone loaded on surface-modified dextran-spooled superparamagnetic nanoparticles with β-cyclodextrin and DNA
Y. Sameena (2018)
Nanoparticle-based drug delivery systems for cancer therapy
Yu Dang (2020)
Stimuli-responsive polymeric nanomaterials for rheumatoid arthritis therapy
Yingsi Xie (2020)
Composite polymeric magnetic nanoparticles for co-delivery of hydrophobic and hydrophilic anticancer drugs and MRI imaging for cancer therapy.
A. Singh (2011)
Electrochemical design of a new nanosensor based on cobalt nanoparticles, chitosan and MWCNT for the determination of daclatasvir: a hepatitis C antiviral drug
S. M. Azab (2017)
Bionanocomposites for Magnetic Removal of Water Pollutants
F. L. Sousa (2015)
Enhancement of magnetic nanoparticle-mediated gene transfer to astrocytes by 'magnetofection': effects of static and oscillating fields.
M. Pickard (2010)
CYTOTOXICITY OF BIODEGRADABLE MAGNETIC NANOCOMPOSITE SPHERES FOR DRUG DELIVERY PURPOSES
Anusha Garikapati (2010)
Innovative Magnetic Scaffold Approaches For Osteochondral Defect
Maurilio Marcacci (2011)
Nanoparticles with targeting, triggered release, and imaging functionality for cancer applications
Kristin H. Loomis (2011)
Cell sorting by endocytotic capacity in a microfluidic magnetophoresis device.
D. Robert (2011)
Dynamic Inversion Enables External Magnets To Concentrate Ferromagnetic Rods to a Central Target
A. Nacev (2015)
NiFe2O4/poly(ethylene glycol)/lipid–polymer hybrid nanoparticles for anti-cancer drug delivery
K. Joshy (2020)
Magnetic nanoparticle synthesis
I. Baker (2018)
Open challenges in magnetic drug
Silvia Muro (2014)
“Smart” liposomal nanocontainers in biology and medicine
Y. Tarahovsky (2010)
Janus arrangement of smart polymer on magnetite nanoparticles through solvent evaporation from emulsion droplets
S. Khoee (2019)
Magnetic nanoparticles and nanocomposites for remote controlled therapies.
Anastasia K. Hauser (2015)
Nanomedical innovation: the SEON-concept for an improved cancer therapy with magnetic nanoparticles.
S. Lyer (2015)See more